Abstract:OBJECTIVE:To investigate the effect of small interfering RNA (siRNA) targeting human vascular endothelial growth factor (hVEGF) on A549 cell growth in nude mice and angiogenesis on chorioallantoic membrane (CAM) assay.METHODS:Three pairs of hVEGF siRNA-plasmid and non-silencing-plasmid were constructed, and transfected into A549 cells through lipofectamine 2000, respectively. The most effective pair of hVEGF siRNA-plasmid was selected by ELISA and real-time RT-PCR. A549 cells transfected with selected hVEGF siRNA- plasmid, A549 cells transfected with non-silencing-plasmid and A549 cells without transfection were inoculated into nude mice, respectively. Chick embryos were randomly divided into four groups and CAM was treated by different solutions for 48 h: culture media DMEM as negative control group,un-transfected A549 cell culture supernatants as positive control group, hVEGF siRNA A549 cell culture supernatants as hVEGF siRNA group and nonsilencing siRNA A549 cell culture supernatants as non-silencing siRNA group. The CAMs were harvested on d12 for microscopic assays.RESULT:Compared with control group, hVEGF siRNA-plasmid induced 48% reduction in hVEGF secretion by A549 cells accompanied by 70% reduction in hVEGF mRNA. Compared with non-silencing siRNA group, the mean tumor volume of murine xenograft was reduced by 58% in hVEGF siRNA group; time for xenografts growing to 50 mm(3)was delayed by 5.4 d. hVEGF contents in xenograft were reduced by 54%; but mean doubling time of tumors and the growth rate of tumors were not significantly reduced. In CAM assays, hVEGF content was zero in negative group, and in hVEGF siRNA group that was 40%-44% of non-silencing siRNA group or positive group; vessels branch points of CAM in hVEGF siRNA group or non-silencing siRNA group or positive group were increased by 45%-55% compared with negative group; total vessel length of CAM in hVEGF siRNA group was increased by 53% compared with negative group, while in non-silencing siRNA group or positive group that was increased by 97% or 99%. Compared with negative control group, the proliferation of microvessels was increased when cell culture supernatant with hVEGF was added in hVEGF siRNA group, significant proliferated vessels were observed in non-silencing siRNA group or positive group.CONCLUSION:A plasmid-mediated hVEGF siRNA has been constructed and verified, which can effectively downregulate the expression of hVEGF in human A549 cells, resulting in the inhibition of angiogenesis. hVEGF siRNA can delay initial growth of A549 tumor xenograft but not reduce the growth rate.

Antisense Drug Targeting with VEGF Mrna Designed by Computer Aid and Inhibitory Effects on K562 Cell Line in Vitro

Inhibition of K562 Cell Growth by Antisense Drug Targeting with VEGF Mrna in Vitro

Design, Screening and Evaluation of VEGF Sirna

[Inhibition of K562 Cell Growth and Tumor Angiogenesis in Nude Mice by Antisense VEGF(121) Cdna Transfection].

RNA Interference Technology for Anti-Vegf Treatment.

[Effects of Vascular Endothelial Growth Factor (VEGF) Antisense Oligodeoxynucleotide on Mrna and Expression of VEGF, Flt-1, and Kinase Insert Domain Containing Receptor and VEGF Excretion in Human Gallbladder Carcinoma Cells].

[Effect and Mechanism of VEGF Antisense Phosphorothioate Deoxynucleotides on HL-60 Leukemic Cells].

Hvegf Sirna Inhibits Initial Growth of A549 Tumor Cells in Nude Mice and Angiogenesis on CAM Assay

[Effect of VEGFR1 Gene Silencing by Shrna on Proliferation, Migration and Apoptosis of U937 Line].

Inhibition of VEGF Expression and SMMC 7721 Cell Growth by VEGFsiRNA

Selection of Effective Bcl-2 Antisense Oligodeoxynucleotides with Computer Software and Experimental Assay

Design,synthesis and Activity Evaluation of Small Interfering RNA Targeting Connective Tissue Growth Factor

Inhibition of VEGF gene expression in Hela cell by short interfering RNAs

Inhibition of VEGFR-1 Gene Expression in U937 Cell Line Using Lentivirus-mediated Shrna

Effect of small interference RNA on vascular endothelial growth factor expression by glioma U251 cells cultured in vitro

Short Hairpin RNA Targeting Vascular Endothelial Growth Factor Inhibits Expression of Vascular Endothelial Cell in Human GBC-SD Cells

Effect of Soluble Vascular Endothelial Growth Factor( VEGF) Receptor Gene (sflt- 1) and Antisense VEGF Nucleotide on Neovascularization

Inhibition of K562 Leukemia Angiogenesis and Growth by Expression of Antisense Vascular Endothelial Growth Factor (VEGF) Sequence

Antisense Candidates Against Protein Kinase C-alpha Designed Based on Phylogenesis and Simulant Structure of Mrna.

Down-regulation of the Vascular Endothelial Growth Factor (VEGF) by a Small Interfering RNA Targeting VEGF in the Nasopharyngeal Carcinoma Cell Line (CNE-2Z)

The Comparison of Antisense Oligonucleotides、small Interferingrna Targeting KDR for Gene Silencing